Logo image of CXT

CRANE NXT CO (CXT) Stock Fundamental Analysis

USA - NYSE:CXT - US2244411052 - Common Stock

56.81 USD
-2.14 (-3.63%)
Last: 9/17/2025, 8:04:00 PM
57.39 USD
+0.58 (+1.02%)
Pre-Market: 9/18/2025, 8:07:42 AM
Fundamental Rating

5

Taking everything into account, CXT scores 5 out of 10 in our fundamental rating. CXT was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. CXT has an excellent profitability rating, but there are concerns on its financial health. CXT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year CXT was profitable.
CXT had a positive operating cash flow in the past year.
CXT had positive earnings in each of the past 5 years.
Each year in the past 5 years CXT had a positive operating cash flow.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

CXT's Return On Assets of 5.19% is fine compared to the rest of the industry. CXT outperforms 73.60% of its industry peers.
The Return On Equity of CXT (12.88%) is better than 84.00% of its industry peers.
With a decent Return On Invested Capital value of 8.52%, CXT is doing good in the industry, outperforming 79.20% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CXT is above the industry average of 9.48%.
The 3 year average ROIC (13.27%) for CXT is well above the current ROIC(8.52%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.19%
ROE 12.88%
ROIC 8.52%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 9.84%, CXT belongs to the top of the industry, outperforming 84.00% of the companies in the same industry.
In the last couple of years the Profit Margin of CXT has declined.
Looking at the Operating Margin, with a value of 17.79%, CXT belongs to the top of the industry, outperforming 92.80% of the companies in the same industry.
CXT's Operating Margin has been stable in the last couple of years.
The Gross Margin of CXT (42.98%) is better than 73.60% of its industry peers.
In the last couple of years the Gross Margin of CXT has remained more or less at the same level.
Industry RankSector Rank
OM 17.79%
PM (TTM) 9.84%
GM 42.98%
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 10 20 30 40

2

2. Health

2.1 Basic Checks

CXT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CXT has more shares outstanding
The debt/assets ratio for CXT is higher compared to a year ago.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.15 indicates that CXT is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.15, CXT is not doing good in the industry: 67.20% of the companies in the same industry are doing better.
CXT has a debt to FCF ratio of 7.66. This is a slightly negative value and a sign of low solvency as CXT would need 7.66 years to pay back of all of its debts.
The Debt to FCF ratio of CXT (7.66) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.96 indicates that CXT is somewhat dependend on debt financing.
CXT has a worse Debt to Equity ratio (0.96) than 88.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 7.66
Altman-Z 2.15
ROIC/WACC0.92
WACC9.28%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CXT has a Current Ratio of 1.20. This is a normal value and indicates that CXT is financially healthy and should not expect problems in meeting its short term obligations.
CXT has a Current ratio of 1.20. This is amonst the worse of the industry: CXT underperforms 86.40% of its industry peers.
A Quick Ratio of 0.89 indicates that CXT may have some problems paying its short term obligations.
With a Quick ratio value of 0.89, CXT is not doing good in the industry: 83.20% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.89
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CXT have decreased by -3.01% in the last year.
CXT shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.61% yearly.
The Revenue has grown by 10.28% in the past year. This is quite good.
CXT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)-3.01%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%-8.49%
Revenue 1Y (TTM)10.28%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%9.12%

3.2 Future

The Earnings Per Share is expected to grow by 8.83% on average over the next years. This is quite good.
Based on estimates for the next years, CXT will show a small growth in Revenue. The Revenue will grow by 7.70% on average per year.
EPS Next Y-2.82%
EPS Next 2Y6.82%
EPS Next 3Y8.83%
EPS Next 5YN/A
Revenue Next Year7.49%
Revenue Next 2Y7.82%
Revenue Next 3Y7.7%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 14.68, CXT is valued correctly.
Based on the Price/Earnings ratio, CXT is valued cheaply inside the industry as 91.20% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.20, CXT is valued a bit cheaper.
CXT is valuated reasonably with a Price/Forward Earnings ratio of 11.66.
CXT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CXT is cheaper than 93.60% of the companies in the same industry.
CXT is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 14.68
Fwd PE 11.66
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CXT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CXT is cheaper than 83.20% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CXT is valued a bit cheaper than 77.60% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.13
EV/EBITDA 10.72
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y6.82%
EPS Next 3Y8.83%

6

5. Dividend

5.1 Amount

CXT has a Yearly Dividend Yield of 1.10%.
Compared to an average industry Dividend Yield of 1.39, CXT pays a better dividend. On top of this CXT pays more dividend than 87.20% of the companies listed in the same industry.
With a Dividend Yield of 1.10, CXT pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
CXT has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CXT pays out 24.98% of its income as dividend. This is a sustainable payout ratio.
The dividend of CXT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP24.98%
EPS Next 2Y6.82%
EPS Next 3Y8.83%
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (9/17/2025, 8:04:00 PM)

Premarket: 57.39 +0.58 (+1.02%)

56.81

-2.14 (-3.63%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners105.25%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner Change1.69%
Market Cap3.26B
Analysts81.82
Price Target91.95 (61.86%)
Short Float %12.2%
Short Ratio16.39
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly Dividend0.64
Dividend Growth(5Y)6.42%
DP24.98%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.17)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.68%
Min EPS beat(2)1.41%
Max EPS beat(2)3.95%
EPS beat(4)3
Avg EPS beat(4)1.23%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)2.1%
EPS beat(12)9
Avg EPS beat(12)6.49%
EPS beat(16)13
Avg EPS beat(16)8.47%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)2.69%
Revenue beat(4)2
Avg Revenue beat(4)-0.12%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)3
Avg Revenue beat(8)0.18%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.64%
PT rev (3m)23.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.05%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-0.29%
Revenue NQ rev (1m)-4.32%
Revenue NQ rev (3m)-0.36%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.87%
Valuation
Industry RankSector Rank
PE 14.68
Fwd PE 11.66
P/S 2.12
P/FCF 22.13
P/OCF 17.03
P/B 2.78
P/tB N/A
EV/EBITDA 10.72
EPS(TTM)3.87
EY6.81%
EPS(NY)4.87
Fwd EY8.58%
FCF(TTM)2.57
FCFY4.52%
OCF(TTM)3.34
OCFY5.87%
SpS26.77
BVpS20.46
TBVpS-10.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.19%
ROE 12.88%
ROCE 11.9%
ROIC 8.52%
ROICexc 9.06%
ROICexgc 33.45%
OM 17.79%
PM (TTM) 9.84%
GM 42.98%
FCFM 9.59%
ROA(3y)8.73%
ROA(5y)6.81%
ROE(3y)20.99%
ROE(5y)16.9%
ROIC(3y)13.27%
ROIC(5y)10.31%
ROICexc(3y)14.97%
ROICexc(5y)11.69%
ROICexgc(3y)57.83%
ROICexgc(5y)41.66%
ROCE(3y)18.35%
ROCE(5y)14.1%
ROICexcg growth 3Y39.7%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.58%
ROICexc growth 5YN/A
OM growth 3Y1.32%
OM growth 5YN/A
PM growth 3Y-2.19%
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.96
Debt/FCF 7.66
Debt/EBITDA 3.05
Cap/Depr 45.56%
Cap/Sales 2.87%
Interest Coverage 5.41
Cash Conversion 51.71%
Profit Quality 97.42%
Current Ratio 1.2
Quick Ratio 0.89
Altman-Z 2.15
F-Score4
WACC9.28%
ROIC/WACC0.92
Cap/Depr(3y)39.82%
Cap/Depr(5y)33.75%
Cap/Sales(3y)2.29%
Cap/Sales(5y)1.89%
Profit Quality(3y)120.27%
Profit Quality(5y)131.76%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.01%
EPS 3Y-13.64%
EPS 5Y-6.61%
EPS Q2Q%-8.49%
EPS Next Y-2.82%
EPS Next 2Y6.82%
EPS Next 3Y8.83%
EPS Next 5YN/A
Revenue 1Y (TTM)10.28%
Revenue growth 3Y3.39%
Revenue growth 5YN/A
Sales Q2Q%9.12%
Revenue Next Year7.49%
Revenue Next 2Y7.82%
Revenue Next 3Y7.7%
Revenue Next 5YN/A
EBIT growth 1Y-1.72%
EBIT growth 3Y4.76%
EBIT growth 5YN/A
EBIT Next Year21.8%
EBIT Next 3Y17.31%
EBIT Next 5YN/A
FCF growth 1Y200.07%
FCF growth 3Y-13.25%
FCF growth 5YN/A
OCF growth 1Y281.35%
OCF growth 3Y-8.23%
OCF growth 5YN/A